Skip to main content
. 2022 Jul 18;12(7):e056370. doi: 10.1136/bmjopen-2021-056370

Figure 2.

Figure 2

Duration (in days) of signs and symptoms across the three groups of participants. Numbers in denominators are participants available at follow-up. Oligo-symptomatic patients are those with symptoms enduring for less than 3 days or with only one symptom (anosmia/ageusia or asthenia). Symptomatic patients are those with one more symptom lasting at least 3 days and without any hospital admission.